Search Results

There are 8114 results for: content related to: Use of Lipid-Lowering Agents in the Prevention of Cardiovascular Disease

  1. Treatment of Dyslipidemia and Cardiovascular Outcomes: The Journey So Far—Is This the End for Statins?

    Clinical Pharmacology & Therapeutics

    Volume 96, Issue 2, August 2014, Pages: 192–205, S Zoungas, A J Curtis, J J McNeil and A M Tonkin

    Article first published online : 11 APR 2014, DOI: 10.1038/clpt.2014.86

  2. Management of Elevated Low-Density Lipoprotein Cholesterol

    Practical Lipid Management: Concepts and Controversies

    Peter P. Toth, Kevin C. Maki, Pages: 63–104, 2008

    Published Online : 1 OCT 2008, DOI: 10.1002/9780470696873.ch5

  3. Potential therapeutic uses for ezetimibe beyond lowering LDL-c to decrease cardiovascular events

    Diabetes, Obesity and Metabolism

    Volume 12, Issue 11, November 2010, Pages: 958–966, M. H. Ahmed and C. D. Byrne

    Article first published online : 12 JUL 2010, DOI: 10.1111/j.1463-1326.2010.01261.x

  4. You have free access to this content
    Ezetimibe: A First-in-Class, Novel Cholesterol Absorption Inhibitor

    Cardiovascular Drug Reviews

    Volume 21, Issue 4, December 2003, Pages: 293–312, Leslie J. Lipka

    Article first published online : 7 JUN 2006, DOI: 10.1111/j.1527-3466.2003.tb00123.x

  5. The Plasma Concentration and LDL-C Relationship in Patients Receiving Ezetimibe

    The Journal of Clinical Pharmacology

    Volume 41, Issue 9, September 2001, Pages: 943–949, F. Ezzet, D. Wexler, P. Statkevich, T. Kosoglou, J. Patrick, L. Lipka, L. Mellars, E. Veltri and V. Batra

    Article first published online : 19 MAR 2013, DOI: 10.1177/009127000104100903

  6. Fixed-dose combination ezetimibe+atorvastatin lowers LDL-C equivalent to co-administered components in randomized trials: use of a dose–response model

    Fundamental & Clinical Pharmacology

    Volume 29, Issue 2, April 2015, Pages: 209–218, Harold E. Bays, Erluo Chen, Joanne E. Tomassini, Gail McPeters, Adam B. Polis and Joseph Triscari

    Article first published online : 27 FEB 2015, DOI: 10.1111/fcp.12096

  7. Population pharmacodynamic analysis of LDL-cholesterol lowering effects by statins and co-medications based on electronic medical records

    British Journal of Clinical Pharmacology

    Volume 78, Issue 4, October 2014, Pages: 824–835, Makoto Kakara, Hiroko Nomura, Masato Fukae, Keisuke Gotanda, Takeshi Hirota, Sunao Matsubayashi, Hideki Shimomura, Masaaki Hirakawa and Ichiro Ieiri

    Article first published online : 19 SEP 2014, DOI: 10.1111/bcp.12405

  8. Effect of ezetimibe/simvastatin compared with atorvastatin on lipoprotein subclasses in patients with type 2 diabetes and hypercholesterolaemia

    Diabetes, Obesity and Metabolism

    Volume 11, Issue 9, September 2009, Pages: 855–864, J. E. Tomassini, T. Mazzone, R. B. Goldberg, J. R. Guyton, R. S. Weinstock, A. Polis, E. Jensen and A. M. Tershakovec

    Article first published online : 5 JUN 2009, DOI: 10.1111/j.1463-1326.2009.01061.x

  9. Reducing Cardiovascular Risk and Managing Dyslipidemia in Women

    Nursing for Women's Health

    Volume 11, Issue 6, December 2007, Pages: 586–599, Susan J. Appel, Natalie A. Floyd and Emily J. Jones

    Article first published online : 7 DEC 2007, DOI: 10.1111/j.1751-486X.2007.00245.x

  10. You have free access to this content
    Safety profile of statins alone or combined with ezetimibe: a pooled analysis of 27 studies including over 22,000 patients treated for 6–24 weeks

    International Journal of Clinical Practice

    Volume 66, Issue 8, August 2012, Pages: 800–812, P. P. Toth, D. Morrone, W. S. Weintraub, M. E. Hanson, R. S. Lowe, J. Lin, A. K. Shah and A. M. Tershakovec

    Article first published online : 16 JUL 2012, DOI: 10.1111/j.1742-1241.2012.02964.x

  11. Improving the odds: ezetimibe and cardiovascular disease

    International Journal of Clinical Practice

    Volume 69, Issue 4, April 2015, Pages: 390–395, A. Viljoen and A. S. Wierzbicki

    Article first published online : 27 MAR 2015, DOI: 10.1111/ijcp.12613

  12. You have free access to this content
    Optimizing lipid lowering in patients at risk

    Clinical Cardiology

    Volume 27, Issue S3, June 2004, Pages: 22–26, Luther T. Clark

    Article first published online : 5 JUL 2007, DOI: 10.1002/clc.4960271507

  13. You have free access to this content
    Cholesterol absorption inhibitors: Defining new options in lipid management

    Clinical Cardiology

    Volume 26, Issue 6, June 2003, Pages: 259–264, W. Virgil Brown

    Article first published online : 5 DEC 2006, DOI: 10.1002/clc.4950260604

  14. The efficacy and safety of ezetimibe/simvastatin combination compared with intensified lipid-lowering treatment strategies in diabetic subjects with and without metabolic syndrome

    Diabetes, Obesity and Metabolism

    Volume 15, Issue 6, June 2013, Pages: 513–522, J. G. Jimenez, J. B. Rosen, V. Pirags, R. Massaad, M. E. Hanson, P. Brudi and J. Triscari

    Article first published online : 25 JAN 2013, DOI: 10.1111/dom.12059

  15. A Case Study of Single-Pill Combination Therapy: The Ezetimibe/Simvastatin Combination for Treatment of Hyperlipidemia

    ChemMedChem

    Volume 7, Issue 11, November 2012, Pages: 1882–1894, Dr. Xianhai Huang and Prof. Dr. David Y.-K. Chen

    Article first published online : 20 AUG 2012, DOI: 10.1002/cmdc.201200287

  16. Ezetimibe added to atorvastatin compared with doubling the atorvastatin dose in patients at high risk for coronary heart disease with diabetes mellitus, metabolic syndrome or neither

    Diabetes, Obesity and Metabolism

    Volume 12, Issue 3, March 2010, Pages: 210–218, S. Conard, H. Bays, L. A. Leiter, S. Bird, J. Lin, M. E. Hanson, A. Shah and A. M. Tershakovec

    Article first published online : 22 SEP 2009, DOI: 10.1111/j.1463-1326.2009.01152.x

  17. The Vytorin on Carotid Intima-Media Thickness and Overall Arterial Rigidity (VYCTOR) Study

    The Journal of Clinical Pharmacology

    Volume 49, Issue 7, July 2009, Pages: 838–847, Dr Alejandra Meaney, Dr Guillermo Ceballos, Dr Juan Asbun, Dr Gustavo Solache, Ms Emma Mendoza, Dr Agustín Vela and Dr Eduardo Meaney

    Article first published online : 7 MAR 2013, DOI: 10.1177/0091270009337011

  18. You have full text access to this OnlineOpen article
    Efficacy and Safety of Alirocumab as Add-on Therapy in High–Cardiovascular-Risk Patients With Hypercholesterolemia Not Adequately Controlled With Atorvastatin (20 or 40 mg) or Rosuvastatin (10 or 20 mg): Design and Rationale of the ODYSSEY OPTIONS Studies

    Clinical Cardiology

    Volume 37, Issue 10, October 2014, Pages: 597–604, Jennifer G. Robinson, Helen M. Colhoun, Harold E. Bays, Peter H. Jones, Yunling Du, Corinne Hanotin and Stephen Donahue

    Article first published online : 30 SEP 2014, DOI: 10.1002/clc.22327

  19. Effect of Pharmaceutical Care on Optimum Colestipol Treatment in Elderly Hypercholesterolemic Veterans

    Pharmacotherapy: The Journal of Human Pharmacology and Drug Therapy

    Volume 17, Issue 3, May-June 1997, Pages: 576–583, Dr Sherri L. Konzem, Dr David R. Gray and Moti L. Kashyap

    Article first published online : 17 JAN 2012, DOI: 10.1002/j.1875-9114.1997.tb03068.x

  20. Long-term efficacy and safety of ezetimibe 10 mg in patients with homozygous sitosterolemia: a 2-year, open-label extension study

    International Journal of Clinical Practice

    Volume 62, Issue 10, October 2008, Pages: 1499–1510, D. Lütjohann, K. Von Bergmann, W. Sirah, G. Macdonell, A. O. Johnson-Levonas, A. Shah, J. Lin, A. Sapre and T. Musliner

    Article first published online : 8 SEP 2008, DOI: 10.1111/j.1742-1241.2008.01841.x